NRP104: Novel Drug Candidate Against Attention Deficit Hyperactivity Disorder (ADHD)
Filed in archive Drugs, Vaccines and Therapeutics on November 23, 2005
Attention deficit hyperactivity disorder (ADHD) is a condition that, according to Frost and Sullivan, is projected to afflict about 6.5 million by 2009, the treatment of which will generate a potential revenue of about $3 billion. With patents on adderall, a drug indicated for ADHD, expiring soon, manufacturer Shire teams up with New River Pharmaceuticals to offer alternative solution.
NRP104, New River Pharma's product candidate, is a conditionally bioreversible derivative (CBD) of amphetamine, a stimulant widely used to treat ADHD. NRP104 is intended to provide better overdose protection and a reduced potential for addiction than currently-marketed amphetamine products.
A second, long-term Phase III efficacy and safety study is ongoing, and the producers anticipate filing for an NDA on NRP104 by the end of 2005. The treatment may be ready for commercialization in about a year.
Source: Washington Business Journal
Tags: ADHD amphetamine adhd biotech nrp104 hyperactivity+disorder deficit+hyperactivity disorder+adhd
Vote for NRP104: Novel Drug Candidate Against Attention Deficit Hyperactivity Disorder (ADHD):
|
Rating: 7.60 out of 5 vote(s) cast.
|
Response from:
M. Simon
(11/27/05 6:22pm)
Response from:
ruth
(11/27/05 11:10pm)
Actually, I'm inclined to agree with you, M Simon, and would take it further: I am skeptic enough to think that it is the parents/caregivers of ADHD children who are "addicted" to such medications, not the patients themselves. But that's just pure speculation...
Response from:
Amphetamine Drug
(12/09/08 11:00pm)
Now day’s many people are suffering from amphetamine drug addition. There are so many amphetamine addiction treatment center running in the country that provides wide varieties of recovery programs to amphetamine drug addiction. If you want to more information about the amphetamine addiction treatment center so you can visit the web site.
http://www.edrugrehabs.com/SubstanceAbuse/Amphetamine-Addiction-Treatm
ents/Rehabs/index.html
http://www.edrugrehabs.com/SubstanceAbuse/Amphetamine-Addiction-Treatm
ents/Rehabs/index.html
Response from:
s
(03/20/11 5:39am)
The Medicine for the Attention Deficit aren`t good. Their has been evidence that the tablets have killed children
and destroyed lives .
Their should be an alternative to a child whose behaviour isnt`t accepted by people .
and destroyed lives .
Their should be an alternative to a child whose behaviour isnt`t accepted by people .
Response from:
shar
(03/20/11 5:40am)
The Medicine for the Attention Deficit aren`t good. Their has been evidence that the tablets have killed children
and destroyed lives .
Their should be an alternative to a child whose behaviour isnt`t accepted by people .
and destroyed lives .
Their should be an alternative to a child whose behaviour isnt`t accepted by people .
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
ml">old
stimulants.